Cable Hill Partners’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-56
Closed -$5K 252
2019
Q1
$5K Hold
56
﹤0.01% 599
2018
Q4
$5K Sell
56
-40
-42% -$3.75K ﹤0.01% 558
2018
Q3
$10K Hold
96
﹤0.01% 425
2018
Q2
$10K Hold
96
﹤0.01% 467
2018
Q1
$9K Sell
96
-33
-26% -$3.38K ﹤0.01% 503
2017
Q4
$12K Sell
129
-28
-18% -$2.65K 0.01% 524
2017
Q3
$15K Sell
157
-39
-20% -$4.14K 0.01% 466
2017
Q2
$22K Hold
196
0.01% 249
2017
Q1
$19K Hold
196
0.01% 262
2016
Q4
$18K Hold
196
0.01% 281
2016
Q3
$16K Buy
196
+124
+172% +$10.4K 0.01% 319
2016
Q2
$6K Hold
72
﹤0.01% 465
2016
Q1
$6K Hold
72
﹤0.01% 439
2015
Q4
$6K Buy
72
+22
+44% +$1.48K ﹤0.01% 430
2015
Q3
$4K Hold
50
﹤0.01% 530
2015
Q2
$4K Buy
+50
New +$3.69K ﹤0.01% 605

Other funds holding DGX

Cable Hill Partners's DGX Position: Q2 2019 in Review

Cable Hill Partners sold out of Quest Diagnostics (DGX) in Q2 2019, closing a stake of 56 shares — an estimated $5K sold.

Cable Hill Partners first reported a position in DGX in Q2 2015 and held it in 16 quarters. The position peaked at $22K in Q2 2017. 654 funds tracked by Wall St. Rank hold DGX as of Q2 2019.

  • Cable Hill Partners reported no remaining Quest Diagnostics position as of Q2 2019 after selling out during the quarter.
  • Cable Hill Partners sold 56 Quest Diagnostics shares in Q2 2019, an estimated $5K.
  • Cable Hill Partners first reported a position in Quest Diagnostics in Q2 2015 and held it in 16 quarters.
  • Cable Hill Partners's Quest Diagnostics position peaked at $22K in Q2 2017.
  • 654 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2019.

Based on Cable Hill Partners's 13F filing for Q2 2019, filed 6 Aug 2019.